Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002598709 | SCV003488615 | uncertain significance | Dyskeratosis congenita, autosomal dominant 6 | 2022-09-15 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs767285943, gnomAD 0.002%). This sequence change affects a donor splice site in intron 4 of the ACD gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), however the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in ACD cause disease. This variant has not been reported in the literature in individuals affected with ACD-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. |
The Telomere Center at Johns Hopkins, |
RCV004565696 | SCV005049648 | pathogenic | Long telomere syndrome | 2023-04-01 | no assertion criteria provided | research |